Cardiff Oncology, Inc.CRDFNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank79
3Y CAGR+93.2%
5Y CAGR+7.1%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+93.2%/yr
vs -6.0%/yr prior
5Y CAGR
+7.1%/yr
Recent acceleration
Acceleration
+99.2pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.14 | +66.0% |
| 2024 | 2.49 | +162.9% |
| 2023 | 0.95 | +65.2% |
| 2022 | 0.57 | -65.6% |
| 2021 | 1.67 | -43.0% |
| 2020 | 2.93 | +189.2% |
| 2019 | 1.01 | +37.9% |
| 2018 | 0.73 | -55.5% |
| 2017 | 1.65 | -48.5% |
| 2016 | 3.21 | - |